Literature DB >> 14726935

Association of glutathione-S-transferase-P1 (GST-P1) polymorphisms with bronchopulmonary dysplasia.

Martha H Manar1, Milton R Brown, Theresa W Gauthier, Lou Ann S Brown.   

Abstract

OBJECTIVE: Reactive oxygen species (ROS) contribute to oxidative lung injury. The glutathione-S-transferases (GST) family and microsomal epoxide hydrolase (mEPHx) enzymes detoxify ROS, and genetic polymorphisms alter this detoxification. We hypothesized that polymorphisms encoding for less efficient enzymes were associated with bronchopulmonary dysphasia (BPD). STUDY
DESIGN: We determined allelic distribution of these polymorphisms in a pilot study of 35 BPD cases and 98 controls. chi2 and regression analysis were performed.
RESULTS: GST P1 val105ile distribution differed between the groups, with the more efficient val/val allele predominantly in controls (p< or =0.05). When controlling for race and sex, BPD cases were less likely to be homozygotes for the val/val isoform (OR 0.21, CI: 0.045-0.95, p=0.04) and more likely to possess the less efficient ile isoform (OR 4.5, CI: 1.0-20.7, p=0.05).
CONCLUSIONS: This pilot study suggests that BPD is associated with the presence of the GST-P1 105ile allele. Future prospective studies are warranted.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14726935     DOI: 10.1038/sj.jp.7211020

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  16 in total

1.  Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia.

Authors:  Alice Hadchouel; Xavier Durrmeyer; Emmanuelle Bouzigon; Roberto Incitti; Johanna Huusko; Pierre-Henri Jarreau; Richard Lenclen; Florence Demenais; Marie-Laure Franco-Montoya; Inès Layouni; Juliana Patkai; Jacques Bourbon; Mikko Hallman; Claude Danan; Christophe Delacourt
Journal:  Am J Respir Crit Care Med       Date:  2011-08-11       Impact factor: 21.405

2.  Glutathione-S-transferase-P1 I105V polymorphism and response to antenatal betamethasone in the prevention of respiratory distress syndrome.

Authors:  Chiara Oretti; Sara Marino; Fabio Mosca; Maria Rosa Colnaghi; Sara De Iudicibus; Ilenia Drigo; Gabriele Stocco; Fiora Bartoli; Giuliana Decorti; Sergio Demarini
Journal:  Eur J Clin Pharmacol       Date:  2009-01-29       Impact factor: 2.953

Review 3.  The role of genetic polymorphisms in antioxidant enzymes and potential antioxidant therapies in neonatal lung disease.

Authors:  Carlo Dani; Chiara Poggi
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

Review 4.  Genetics of bronchopulmonary dysplasia in the age of genomics.

Authors:  Pascal M Lavoie; Marie-Pierre Dubé
Journal:  Curr Opin Pediatr       Date:  2010-04       Impact factor: 2.856

5.  Potential therapeutic targets in Nrf2-dependent protection against neonatal respiratory distress disease predicted by cDNA microarray analysis and bioinformatics tools.

Authors:  Hye-Youn Cho; Xuting Wang; Jianying Li; Douglas A Bell; Steven R Kleeberger
Journal:  Curr Opin Toxicol       Date:  2016-10-29

Review 6.  Association of Nrf2 with airway pathogenesis: lessons learned from genetic mouse models.

Authors:  Hye-Youn Cho; Steven R Kleeberger
Journal:  Arch Toxicol       Date:  2015-07-21       Impact factor: 5.153

7.  Aurothioglucose enhances proangiogenic pathway activation in lungs from room air and hyperoxia-exposed newborn mice.

Authors:  Katelyn Dunigan-Russell; Vivian Lin; Mary Silverberg; Stephanie B Wall; Rui Li; John Gotham; Teodora Nicola; Anusha Sridharan; John Snowball; Cassidy Delaney; Qian Li; Trent E Tipple
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-04-15       Impact factor: 5.464

8.  Recurrent copy number variants associated with bronchopulmonary dysplasia.

Authors:  Ausaf Ahmad; Soumyaroop Bhattacharya; Arthi Sridhar; Anwar M Iqbal; Thomas J Mariani
Journal:  Pediatr Res       Date:  2016-03-14       Impact factor: 3.756

9.  Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health.

Authors:  Pascal M Lavoie; Chandra Pham; Kerry L Jang
Journal:  Pediatrics       Date:  2008-09       Impact factor: 7.124

10.  Glutathion-S-Transferase P1 polymorphisms association with broncopulmonary dysplasia in preterm infants.

Authors:  P Karagianni; D Rallis; L Fidani; M Porpodi; K Kalinderi; C Tsakalidis; N Nikolaidis
Journal:  Hippokratia       Date:  2013-10       Impact factor: 0.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.